PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline • CRPC PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Pipeline landscape PART 07: Market segmentation by therapy • Hormonal therapy • Chemotherapy • Others PART 08: Geographical segmentation • CRPC treatment market in Americas • CRPC treatment market in EMEA • CRPC market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Increasing consolidation in cancer treatment market • Emergence of targeted therapies and immunotherapies PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • Astellas Pharma • Johnson & Johnson • Sanofi • Valeant • Other prominent vendors PART 14: Appendix • List of abbreviations

Astellas Pharma, Johnson & Johnson, Sanofi, Valeant, Active Biotech, Advaxis, ANI Pharmaceuticals, Athenex, Bavarian Nordic, Bayer, Bristol-Myers Squibb, CureVac, GlaxoSmithKline, Innocrin Pharmaceutical, Merck, Myovant Sciences, Northwest Biotherapeutics, OncoGenex Pharmaceuticals, Oncolytics Biotech, Orion, Sotio, Madrigal Pharmaceuticals, Takeda Pharmaceutical, and Teva Pharmaceutical Industries